The Karen Toffler Charitable Trust Commits $330,000 to Help Advance Vital Early-Stage Medical Research

Los Angeles, CA, October 7, 2020  The Karen Toffler Charitable Trust (KTCT) today announced that it has committed $330,000 to continue its support of transformative medical research. The funding is primarily being allocated through the Toffler Scholar Program to support researchers at six universities. Funds also will be directed toward research organizations working in the areas of dementia research, medical technology, and cutting-edge diagnostic testing. KTCT selected these recipients based on their efforts to advance high-impact, early-stage medical research. 

The University of Florida and the University of California at Los Angeles received renewed funding from the trust. For 2020, the entity added four new partners — Boston University, Florida State University, Temple University, and Johns Hopkins University. In every case, the funds are being used to help young researchers at a pivotal point in their careers by creating a financial and network support bridge to a phase where large research grants are more available.

With this thoughtful investment, KTCT is doing its part to help solve some of the world’s most intractable problems. The human toll of neurological conditions is tremendous. With dementia alone, these medical breakthroughs could reduce the 10 million new global cases annually, slowing the cost to society that is rapidly growing into the trillions. It is part of the commitment by the charitable organization to carry on the powerful legacy of our founders, Alvin and Heidi Toffler by seeing and investing in the work that has the potential for profound impact on the future of humanity.

“It’s our responsibility and our privilege to welcome these visionary partners into the enduring commitment set by the Tofflers,” said Rebecca Bartoli, executive director of the Karen Toffler Charitable Trust. “Without these brilliant scientists, we couldn’t move the Toffler’s vision forward, and without us, these researchers might not advance as quickly. It’s a true partnership for the good of the global population.”

“We are careful when selecting our grant recipients because we want to maximize the potential to build a better future,” said Russ Glassman, board member. “These funds have been distributed thoughtfully as just one part of the lasting, productive relationships we’re building.”